Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

Liquid biopsy has emerged as an alternative source of nucleic acids for the management of Epidermal Growth Factor Receptor (EGFR)-mutant non-Small Cell Lung Cancer (NSCLC). The use of circulating cell-free DNA (cfDNA) has been recently introduced in clinical practice, resulting in the improvement of...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Re, Marzia, Crucitta, Stefania, Gianfilippo, Giulia, Passaro, Antonio, Petrini, Iacopo, Restante, Giuliana, Michelucci, Angela, Fogli, Stefano, de Marinis, Filippo, Porta, Camillo, Chella, Antonio, Danesi, Romano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720634/
https://www.ncbi.nlm.nih.gov/pubmed/31416192
http://dx.doi.org/10.3390/ijms20163951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720634/
https://www.ncbi.nlm.nih.gov/pubmed/31416192
http://dx.doi.org/10.3390/ijms20163951

Ejemplares similares